Posted by Michael Wonder on 02 Mar 2021
GC Pharma submits biologics license application to US FDA for immune globulin 'GC5107'
25 February 2021 - Submission for entering the world’s largest US marketplace.
GC Pharma today announced that it had submitted its biologics license application for 'GC5107' (immune globulin intravenous (human), 10% liquid) to the United States FDA.
